Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic reviewArsela Prelaj, A.L.G. Pedrocchi, M. A. Favali et al.|Annals of Oncology|2023Cited by 286
Activity and safety of first-line treatments for advanced melanoma: A network meta-analysisAndrea Boutros, Francesco Spagnolo, Enrica T. Tanda et al.|European Journal of Cancer|2023Cited by 38
Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with NivolumabCarlo Genova, Francesco Grossi|Journal of Clinical Medicine|2019Cited by 33
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literatureAndrea Boutros, Carlo Genova, Alberto Bottini et al.|ESMO Open|2023Cited by 21
Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinomaAndrea Boutros, Francesco Spagnolo, Enrica T. Tanda et al.|Journal of Geriatric Oncology|2023Cited by 7